Navigation Links
Mesa Labs Reports Record Year End Sales and Earnings
Date:5/19/2008

ogger market in the months ahead. With this significant new product for DataTrace and good sales growth momentum in our other two core product lines, Raven and Medical, we expect another solid year for Mesa in fiscal 2009."

During fiscal 2008, sales of the Company's medical products and services increased five percent for the fiscal year and decreased three percent during the fourth quarter compared to prior year periods. For the year, Medical saw increased sales of meter products, disposables and service, which were partially off-set by lower sales of the discontinued dialyzer reprocessor line and lower repair part sales. For the fourth fiscal quarter, higher sales of disposable products and service were off-set by lower sales of dialyzer reprocessors, meters and repair parts.

Fiscal 2008 fourth quarter sales of Raven biological indicator products increased 33 percent compared to the prior year period. The Raven biological indicator products were acquired on May 4, 2006. For this reason, sales of the company's Raven biological indicator products benefited from an extra five weeks of sales for the full year when compared to the prior year period and were up 29 percent.

During fiscal 2008, sales of DataTrace data logger products increased compared to the prior year. For the year, DataTrace sales increased 13 percent, while the quarterly sales were up five percent compared to the same periods last year. For both the quarter and year, DataTrace products continue to see improving trends in both new product shipments and service sales in both the domestic and international markets. Introduction of the new Micropack RF products, with their real-time reporting capabilities, is expected to further add to DataTrace product line sales in the new fiscal year.

During fiscal 2008, sales of the Nusonics line of ultrasonic fluid measurement systems decreased by three percent. Sales of these products remain stable, but Nusonics products currently contrib
'/>"/>

SOURCE Mesa Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. BMP Sunstone Reports First Quarter 2008 Financial Results
2. Huiheng Medical, Inc. Reports Record Financial Results for Fiscal Year 2007 and Financial Results for Q1 2008
3. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
4. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
5. China Yingxia International, Inc. Reports First Quarter 2008 Results
6. Digital Power Reports Financial Results for the First Quarter Ended March 31, 2008
7. Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008
8. Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
9. Nephros Reports 2008 First Quarter Financial Results
10. PreMD Reports First Quarter Results
11. Lifeway Foods Reports Record 1st Quarter 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ings at Stevens Institute of Technology will prese..., journalist and founder, Bloggingheads.tv, Wednes...o Center for Technology Management, Room 122. The ...., In his new book "The Evolution of God," the b...his popular works on evolutionary psychology, pres...
(Date:11/23/2009)...elf-reported by American surgeons are strongly rel...s appear today in the online edition of Annals of...aborators from Johns Hopkins and the American Coll... nearly 9 percent of U.S. surgeons responding said... to being surveyed. Over 70 percent attributed the...
(Date:11/23/2009)... Society of America (IDSA) has asked for a commitm... Union to further the Society,s mission to achieve...next 10 years, known as the 10 x ,20 Initiative. ... antimicrobial resistance as one of the three grea...nion report confirms there are just 15 antibacteri...
(Date:11/23/2009)... more screen time than those in center-based care,...Day News) --Young children of working parents may ... reports have found, especially kids in home-based...chers from Seattle Children,s Hospital and the Uni...to find out how much television viewing was availa...
(Date:11/23/2009)...announce its participation in the 2009 CR report c...ssible amongst all major CR vendors. iCRco is the ...n sales, service and technology fields and scored ...nality. iCRco is very pleased to have been rated w...arch firm in medical imaging, KLAS. , ...
Breaking Medicine News(10 mins):Health News:Burnout and mental distress strongly related to errors by US surgeons 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 2Health News:10 x '20: ID experts call for 10 new antibiotics by 2020 3Health News:Day Care Boosts Kids' TV Time 2Health News:Day Care Boosts Kids' TV Time 3Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 2Health News:iCRco is the Only CR Vendor to Receive the Highest Grade “A” in All Fields by KLAS 3
...ges dedicated to disseminating breast cancer infor...titutions in the Houston have determined that whil...e, one in 20 breast cancer Web pages featured inac...Published in the March 15 issue of Cancer and onli...
...CVD) today announced that it will present at the U...ry 11th at 1:30 pm ET. Investors may access a,live...e.com . In order to register,and download any nece...nsive drug development services companies,with ann...
... voluntary recall by Chattem, Inc., announced it i.... Chattem is recalling these products based on,con...rns as well as skin,irritation resulting from cons... 1. Icy Hot Heat Therapy Air Activated Heat- Back ...
...ine,s Day gift than the,"gift of life?", WASHINGT...e have held more than 1,900 community donor drives...with local blood center partners,as part of Saturn...o and the South Texas Blood and Tissue,Center. The...
...anie Tubbs Jones announced that six new constructi...d for the Louis Stokes Cleveland VA Medical,Center...g for the new,construction was made possible by a ...I am extremely pleased that we were able to secure...
...ogy Holdings, Inc. (Nasdaq: NHWK ), a leading pro...ross the United States, announced today that,the t...ngs conference call,has been changed to February 1...ourth quarter and full-year 2007 conference call w...
Other Medicine News:Health News:Review of online breast cancer information encourages healthy skepticism for consumers 2Health News:Giant Food Alerts Customers to Voluntary Recall of Chattem Icy Hot Heat Therapy Products 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 2Health News:Saturn Celebrates 11 Years of Helping Save Lives Through Blood, Marrow, Organ and Tissue Donation 3Health News:NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call 2
(Date:11/23/2009)..., THEWOODLANDS,Texas,Nov.23/PRNewswire-FirstC...,announcedtodaythattop-linedatafromitsPhase2clinic...rritablebowelsyndrome(IBS)willbepresentedatGASTRO2...dasignificantimprovementinIBSsymptoms,willbepresen...ntofclinicaldevelopment,onNovember25,2009at2:30pml...
(Date:11/23/2009)..., EXTON,Pa.,Nov.23/PRNewswire/--BioTrendsRese...M): Feraheme report,thesecondinamulti-phasesyndi...snewIVironproduct,Feraheme,throughthefirstsixmonth...quantitativeinformationfrom50uniqueNephrologistsan...ssesstrialanduseofFeraheme,obstaclestouse,reasonst...
(Date:11/23/2009)..., FORTWORTH,Texas,Nov.23/PRNewswire-FirstCall...ard:WNDM)arapidlygrowingproviderofspecialtymedical...esultsandhasprovidedacomprehensivemanagementbusine...lendaryear. ,, Q32009salesincreased33.5%to$102...ityasoftheQ32009increasedto$3,327,892vs.Q32008shar...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Medicsight Announces Global Agreement With Alma IT Systems 50043 1Medicsight Announces Global Agreement With Alma IT Systems 50043 2Medicsight Announces Global Agreement With Alma IT Systems 50043 3Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 1Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 2Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 3Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 4Case Western Reserve University Receives 245M From Third Frontier Commission for the Center for Stem Cell 26 Regenerative Medicine 50041 5BIO Ventures for Global Health Announces Management Changes 12785 1BIO Ventures for Global Health Announces Management Changes 12785 2
...icals,Inc. (Nasdaq: JAZZ ) today announced compl... pivotal clinical trials of JZP-6 (sodium oxybate)...ion of enrollment in this second trial is a meanin...a. We expect to report top-line results,from this... Executive Officer. , The JZP-6 Phase III clin...
...he Swedish,fragment-based drug discovery company, ...ment with GE Healthcare (Chalfont St. Giles, UK), ...n analysis tools, and Uppsala,University (Sweden...proach to,fragment-based drug discovery and GE Hea...xpertise from Uppsala University . , (Logo: ...
Other Medicine Technology:Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 2Jazz Pharmaceuticals, Inc. Completes Enrollment in Second of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia 3Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University 2
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
...rence laboratory and a worldwide leader in innovat...rs an extensive test menu of highly complex and un...ogy. Owned by the University of Utah, ARUP Laborat...n's university teaching hospitals and children's h...
Medicine Products: